BVI diversifies product offering

Andrew Madeswi PIC: PHATSIMO KAPENG
Andrew Madeswi PIC: PHATSIMO KAPENG

In pursuit of its “Four for Forty” strategic goal, the Botswana Vaccine Institute (BVI) will launch a new blending and filling facility at its vaccine manufacturing plant in Gaborone.

The facility will enable BVI to diversify its product offering from Foot and Mouth Disease (FMD) vaccines to other animal solutions, penetrate new markets and improve its production, warehousing and distribution capacities.

The blending and filling facility meets international vaccine standards set by the World Organization for Animal Health (WOAH) as well as to Good Manufacturing Practice (GMP), which will enable BVI to not only expand its product range but also gain access to new lucrative international markets.


Editor's Comment
A collective responsibility to end FMD spread

As cases continue to threaten herds and rural livelihoods, one simple but critical action can make a powerful difference: strictly adhering to FMD regulations, including refraining from slaughtering cloven-hoofed animals.Cloven-hoofed animals, such as cattle, sheep, goats, and pigs, are highly susceptible to FMD. Slaughter, especially during outbreaks or restricted periods, significantly increases the risk of spreading the virus through...

Have a Story? Send Us a tip
arrow up